Research and Markets: Boots International Announced The Sale of Its US OTC Healthcare Business To Reckitt Benckiser - Analgesics in the USA

Business Wire, August 14, 2006

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c40546) has announced the addition of Analgesics in the USA to their offering.

Market exits as companies focus on Rx business

The US OTC healthcare market was a changing landscape in 2005 as Bristol-Myers Squibb and Boots International both decided to exit in order to focus on their prescription drug businesses. Bristol-Myers Squibb sold its US and Canadian consumer health portfolio, including rights to the Excedrin, Vagistat and Comtrex brands, to Novartis.

Boots International announced the sale of its US OTC healthcare business to Reckitt Benckiser. The deal includes the Clearasil, Nurofen and Strepsils brands. Wyeth also sold its Solgar Vitamin and Herb division to NBTY during 2005. Finally, Pfizer has announced its intention to sell its consumer healthcare division, a move that promises to impact the US OTC healthcare market even more in 2006.

These market exits signal a greater trend for pharmaceutical companies to focus on the more profitable prescription drug market at the expense of OTC healthcare innovations, and such transitions of ownership have slowed the pace of new product development and overall growth in OTC healthcare sales.

The Analgesics in the United States report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

- Get a detailed picture of the analgesics industry
- Pinpoint growth sectors and trends and identify factors driving
  change
- Understand the competitive environment, the market's major players
  and leading brands
- Use five-year forecasts to assess how the market is predicted to
  develop

Contents Include:-

1. Executive Summary

2. Operating Environment

3. OTC Healthcare Sales

4. Analgesics Sales

5. Definitions

Companies Mentioned are:

- McNeil Consumer & Specialty Pharmaceuticals
- Wyeth Consumer Healthcare Inc
- Pfizer Consumer Healthcare Ltd
- Procter & Gamble Co, The
- GlaxoSmithKline Consumer Health
- NBTY Inc
- Bayer Corp
- Novartis Corp
- Schering-Plough Healthcare Products Inc
- Johnson & Johnson Consumer Products Inc
- Pharmavite Corp
- General Nutrition Centers Inc
- Amway Corp
- Herbalife International Inc
- Adams Respiratory
- Therapeutics Inc
- Johnson & Johnson-Merck Consumer Pharmaceuticals Co
- Mannatech Inc
- Forever Living Products LLC
- Chattem Inc
- Cadbury Adams USA LLC
- Rexall Sundown Inc
- Advanced Care Products
- Nature's Sunshine Products Inc
- Bausch & Lomb Inc
- Neutrogena Corp
- Life Extension Foundation Inc
- Tahitian Noni International Inc
- Twinlab Corp
- Sunrider International Inc
- Airborne Inc
- Bristol-Myers Squibb Co
- Weider Nutrition International Inc
- Bayer-Roche LLC
- General Nutrition Cos Inc
- Mentholatum Co Inc, The
- Medtech Inc
- Rhone-Poulenc Rorer Inc
- Hi-Tech Pharmacal Co, Inc
- Hisamitsu America Inc
- Medicis Pharmaceutical Corp
- Pharmacia Corp
- WF Young Inc
- Naturopathica Ltd
- Whitehall-Robins Healthcare
- Leiner Health Products Inc

For more information visit http://www.researchandmarkets.com/reports/c40546